E-Therapeutics Plc (ETXP)

London
17.25
-0.75(-4.22%)
  • Volume:
    354,107
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    17.00 - 17.90

ETXP Overview

Prev. Close
17.75
Day's Range
17-17.9
Revenue
480K
Open
17.9
52 wk Range
15.48-49.5
EPS
-0.02
Volume
354,107
Market Cap
91.34M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
187,873
P/E Ratio
-
Beta
-0.32
1-Year Change
-22.66%
Shares Outstanding
514,571,069
Next Earnings Date
23 Oct 2022
What is your sentiment on E-Therapeutics?
or
Market is currently closed. Voting is open during market hours.

E-Therapeutics Plc Company Profile

E-Therapeutics Plc Company Profile

Employees
35

e-Therapeutics Plc provides computer-based drug discovery platform. The Company's platform is a combination of databases and a suite of computational tools that employ network analysis, data mining, machine learning, artificial intelligence (Al) and optimization. Its in silico platform serves as a laboratory, which enables it to computationally test potential therapeutic interventions. Its network-driven drug discovery (NDD) technology performs computational phenotypic screens to identify efficacious drugs. Its genome-associated interactions networks (GAINs) technology interprets genomic data in the context of the biological networks, in which the genes function. Its ribonucleic acid (RNA) Interference, (RNAi) platform is in development to complement its computational toolset. The Company identifies new therapeutic approaches to modulate a specific mechanism involved in Idiopathic Pulmonary Fibrosis (IPF) and other fibrotic indications through Galapagos NV (Galapagos).

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellSellStrong Sell
Technical IndicatorsStrong BuyStrong BuyBuyBuyStrong Sell
SummaryNeutralNeutralNeutralNeutralStrong Sell
  • I guess people will reflect on the panic over the weekend and buy back on Monday.
    0
    • impressive 👍
      0
  • 35p
    0